These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 14053348)
21. Experience with a new cholecystographic medium (telepaque). SPENCER FM Gastroenterology; 1952 Aug; 21(4):535-9. PubMed ID: 14955021 [No Abstract] [Full Text] [Related]
22. An evaluation of telepaque; a new cholecystographic medium. LOWMAN RM; STANLEY HW Conn State Med J; 1952 Aug; 16(8):591-3. PubMed ID: 12979500 [No Abstract] [Full Text] [Related]
23. [Comparative cholecystographic study of iodopanoic acid (telepaque) and iodoalphionic acid]. CLAUS E; BAEYENS J J Belge Radiol; 1953; 36(1):17-48. PubMed ID: 13096516 [No Abstract] [Full Text] [Related]
24. A preliminary evaluation of a new cholecystographic medium "telepaque". LOWMAN RM; STANLEY HW; EVANS TS; MENDILLO JC Gastroenterology; 1952 Jun; 21(2):254-62. PubMed ID: 14937211 [No Abstract] [Full Text] [Related]
25. A preliminary report on telepaque, a new cholecystographic medium. CHRISTENSEN WR; SOSMAN MC Am J Roentgenol Radium Ther; 1951 Nov; 66(5):764-8. PubMed ID: 14878058 [No Abstract] [Full Text] [Related]
26. [Iodoxanic acid, a new oral cholecystographic contrast medium: comparison with iodopanoic acid]. Orlandini I Radiol Med; 1970 Sep; 56(9):832-5. PubMed ID: 5210611 [No Abstract] [Full Text] [Related]
27. Experiences with telepaque, a new cholecystographic medium. RENCK L Acta radiol; 1954 Apr; 41(4):336-42. PubMed ID: 13158134 [No Abstract] [Full Text] [Related]
28. Sodium tyropanoate, a new oral cholecystographic agent. Hoppe JO; Ackerman JH; Larsen AA; Moss J J Med Chem; 1970 Sep; 13(5):997-9. PubMed ID: 5458405 [No Abstract] [Full Text] [Related]
29. Telepaque: a new cholecystographic medium with improved visualization of the bile ducts. SHEHADI WH Am J Roentgenol Radium Ther Nucl Med; 1952 Sep; 68(3):360-8. PubMed ID: 14952612 [No Abstract] [Full Text] [Related]
30. Observations on a series of aryl triiodo alkanoic acid derivatives with particular reference to a new cholecystographic medium, telepaque. HOPPE JO; ARCHER S Am J Roentgenol Radium Ther Nucl Med; 1953 Apr; 69(4):630-7. PubMed ID: 13030919 [No Abstract] [Full Text] [Related]
35. PRECAUTIONS INDICATED WITH CHOLECYSTOGRAPHIC AGENTS. NELSON E; LEVY G Arch Surg; 1964 Jun; 88():921-2. PubMed ID: 14131997 [No Abstract] [Full Text] [Related]
36. ATHROMBOCYTOSIS FOLLOWING ORAL CHOLECYSTOGRAPHY. BISHOPRIC GA JAMA; 1964 Sep; 189():771-2. PubMed ID: 14174059 [No Abstract] [Full Text] [Related]
37. ORAGRAFIN AS A SUPPLEMENTAL CONTRAST AGENT IN ORAL CHOLECYSTOGRAPHY. RICHARDSON GA; SCHREIBER MH Tex State J Med; 1963 Aug; 59():788-9. PubMed ID: 14044597 [No Abstract] [Full Text] [Related]
38. A comparative clinical study of two cholecystographic agents. Fischer HW; Patterson FE; Pitman RL Invest Radiol; 1971; 6(4):249-54. PubMed ID: 4935916 [No Abstract] [Full Text] [Related]
39. Residual contrast medium in the bowel in cholecystography with iopanoic acid and certain related substances. ANDREN L; THEANDER G Acta radiol; 1960 May; 53():371-6. PubMed ID: 13793563 [No Abstract] [Full Text] [Related]